AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pasithea Therapeutics Corp. Director's Dealing 2022

Jun 23, 2022

Director's Dealing

Opens in your device viewer

Issuer: Pasithea Therapeutics Corp. (KTTA)
CIK: 0001841330
Period of Report: 2022-06-23

Reporting Person: Marques Tiago (Director, Chief Executive Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-23	Common Stock	A	2900	$0.993	Acquired	802900	Direct
2022-06-23	Common Stock	A	200	$0.982	Acquired	803100	Direct
2022-06-23	Common Stock	A	100	$0.988	Acquired	803200	Direct
2022-06-23	Common Stock	A	1800	$0.994	Acquired	805000	Direct